NL-OMON32239招募中不适用
Radiolabelled Interleukin-2 for the study of vulnerable carotid plaque in patients with long-term statin treatment: a pilot study. - RITS
uclaire geneeskunde en moleculaire beeldvorming0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Scheduled carotis endartiectomy
- •More than 3 months on statin therapy
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Phase II clinical trial of interleukin-2, interferon-alpha and tegafur uracil therapy for advanced renal cell canceradvanced renal cell cancerJPRN-UMIN000002222Department of Urology Faculty of Medicine50
已完成
1 期
Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune SystemsHIV InfectionsNCT00006066National Institute of Allergy and Infectious Diseases (NIAID)92
已完成
1 期
A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected ChildrenHIV InfectionsNCT00000849National Institute of Allergy and Infectious Diseases (NIAID)27
已完成
不适用
Efficacy of subcutaneous interleukin-2 (IL-2) in the treament of advanced HIV-1 infections in persons with CD4+ T lymphoytes <100/mm3 and undetectable plasma viral loadInfections and Infestations: Human immunodeficiency virus (HIV)Infections and InfestationsHuman immunodeficiency virus (HIV)ISRCTN34382898Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)30
已完成
2 期
A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV TherapyHIV InfectionsNCT00000909National Institute of Allergy and Infectious Diseases (NIAID)36